Fig. 6From: How we read: the combined use of MRI and novel PET tracers for the characterisation and treatment planning of masses in neuro-oncologyFDG-PET (a) performed for follow-up of a patient with a germline succinate dehydrogenase subunit B mutation and a known left glomus jugulare paraganglioma (arrowhead) demonstrates a new area of FDG-avidity just below the skull base on the right (arrow). The subsequent post-contrast MRI (b) supports that this is a new paraganglioma rather than a metastasisBack to article page